WeedLife News Network

Hot off the press cannabis, marijuana, cbd and hemp news from around the world on the WeedLife Social Network.

Ohio Officials Seek Public Comments on Medical Cannabis Conditions

Ohio is now taking written comments on the qualifying conditions it is thinking of adding to the medical cannabis program. 

Through February 26, residents of Ohio will have a chance to comment on conditions including autism, Huntington’s disease, panic disorder with agoraphobia, restless leg syndrome, spasticity and spasms, and terminal illness.

These public comments will be reviewed by the Medical Marijuana Committee, who is currently reviewing 30 different potential conditions that have been suggested.

More than 30 qualifying conditions were suggested to the committee, but many were rejected, either because they are already allowed, petitions were incomplete, or there was not enough evidence listed from professional studies showing cannabis could help with the condition. 

The Medical Marijuana Committee will be reviewing these comments on March 8, looking more deeply into the qualifying conditions they have decided to consider. They will then vote on the next six conditions that will be approved. 

e-mail icon
Continue reading

Study Shows Cannabis Lowers Blood Pressure in Hypertension Patients

A new study that looks at blood pressure in older adults with hypertension saw a connection between cannabis use and a reduction in systolic and diastolic blood pressure, findings that are significant for those who suffer from the two ailments. 

The study, titled “Cannabis is associated with blood pressure reduction in older adults – A 24-hours ambulatory blood pressure monitoring study” carried out by Ran Abuhasira, M.D., of Ben-Gurion University of the Negev and his team, located in Israel, and published in the European Journal of Internal Medicine in January of this year, looked at patients 60 or older with hypertension and medical cannabis prescriptions. The study then monitored their rates of use and their blood pressure. The patients then underwent blood tests, monitoring, and other medical procedures during the course of three months, as they actively used cannabis to manage their conditions. 

The researchers looked at a total of 26 cannabis patients, of which exactly 53.8 percent were female. The findings showed that, while no big changes were seen in the ECG exam results of the patients study, blood pressure was overall lower in those with hypertension who were consistently using medical cannabis. 

“The proportion of normal dippers changed from 27.3 percent before treatment to 45.5 percent afterward,” the study said regarding the percentage of people whose blood pressure levels dipped. “No significant changes were seen in the different metabolic parameters assessed by blood tests, anthropometric measurements, or ECG exam.”

“Medical cannabis use is increasing rapidly in the past several years, with older adults being the fastest growing group,” it continued. “Nevertheless, the evidence for cardiovascular safety of cannabis use is scarce. The aim of this study was to assess the effect of cannabis on blood pressure, heart rate, and metabolic parameters in older adults with hypertension.”

e-mail icon
Continue reading

Oral Health And Weed: Could Marijuana Prevent Cavities?

A study found that cannabinoids have the potential to be used as an effective antibacterial agent against dental plaque-associated bacteria.

January 2020 study published in the Cureus Journal of Medical Science found something remarkable about marijuana’s effect on oral health. The study looked at the effect of marijuana or THC on dental plaque, a film that forms on the teeth and gums that can lead to heart disease. Examining the efficacy of multiple oral care products and cannabinoids together, researchers wanted to gauge which reduced plaque bacteria better.

Featuring 60 adults 18- to 65-years-old, individuals were screened for gum health and placed into six groups, based on their level of gum disease. Researchers scraped each individual in the six groups and placed the samples within individual petri dishes by type.


Photo by Peter Kasprzyk via Unsplash

Petri Dish A included:

Cannabidiol (CBD)Cannabichromene (CBC)Cannabinol (CBN)Cannabigerol (CBG)

Petri Dish B included:

Oral Health And Weed: Could Marijuana Prevent Cavities?
Continue reading

South Dakota Governor Delays Implementation of Medical Marijuana Initiative

South Dakota Gov. Kristi Noem announced on Wednesday that she is seeking to delay the implementation of a successful voter initiative to legalize medical marijuana. The state’s voters approved Initiated Measure 26 (IM 26) to allow qualified patients to use cannabis medicinally in the November general election with nearly 70% of votes cast.

Under South Dakota law, initiatives and amendments are supposed to go into effect on July 1 of the year following passage. But Noem announced this week that she is seeking to delay the implementation of the medical marijuana initiative by one year, with the support of fellow Republicans in the South Dakota Senate and House of Representatives.

“We are working diligently to get IM 26 implemented safely and correctly,” Noem said in a statement released by her office on Wednesday morning. “The feasibility of getting this program up and running well will take additional time. I am thankful to our legislative leaders for helping make sure that we do this right.”

To effect the change, lawmakers introduced House Bill 1100 in the House State Affairs Committee on Wednesday morning. The measure amends a pending state statute prompted by the passage of IM 26 and replaces several instances citing the original start date of the measure with the date “July 1, 2022.” The bill also creates a legislative task force to draft legislation legalizing medical marijuana while addressing issues left unclear in the initiative, such as which methods of consumption should be allowed to comply with a requirement that schools accommodate medical marijuana use by qualified patients.

Consulting Firm Cited To Justify Delay

To justify the delay, Noem cited a letter from Cannabis Public Policy Consulting (CPPC), a firm that has assisted state and local governments across the country and in Canada with the implementation of cannabis legalization measures. According to CPPC, creating a safe, efficient, and effective medical marijuana program takes an average of 14 months.

e-mail icon
Continue reading

Marijuana may significantly lower blood pressure in older users

A new study reports that cannabis use may lower blood pressure in older adults, though additional research is necessary to get a better understanding of the substance’s effect on cardiovascular health. The research comes from the Ben-Gurion University of the Negev and the Soroka University Medical Center; it was recently published in the European Journal of Internal Medicine.

 

The increasing legalization of marijuana, as well as medical marijuana programs, has resulted in a growing number of people — including older adults — consuming the substance for various potential health benefits. Use for chronic pain issues is one driving factor behind medical marijuana use, and the researchers say that pain relief may help explain why cannabis use is associated with lowered blood pressure in older adults.

The study focused on adults ages 60 and older who were diagnosed with high blood pressure (hypertension). Using data from ECG, 24-hour ambulatory blood pressure monitoring, and more, the study found that marijuana use was associated with a ‘significant’ drop in both diastolic and systolic blood pressure over a 24-hour period, with the lowest point occurring three hours after use.

The participants consumed marijuana in the form of smoking and oil extracts, the study notes, also reporting that while blood pressure decreased during both the day and night, the nighttime decrease was more significant. BGU Faculty of Health Sciences’ Dr. Ran Abuhasira said:

e-mail icon
Continue reading

More Local Cannabis Dispensaries May Mean Fewer Opioid Overdose Deaths

One way to reduce opioid overdose death rates in American communities may be to expand legal access to another, less lethal drug. A study published in January 2021 in the BMJ suggests that U.S. counties that have more cannabis dispensaries also have lower opioid-related deaths

The study focused on 812 counties in 23 U.S. states and the District of Columbia that allowed cannabis dispensaries to sell recreational or medical marijuana. Across all the counties in the study, the average number of cannabis dispensaries increased from slightly less than one per county in 2014 to more than four by 2018.

When the number of cannabis dispensaries in a county increased from one to two, researchers estimated that overall opioid mortality rates fell by 17 percent.

Death rates from synthetic opioids like fentanyl, which are responsible for a greater proportion of opioid fatalities in the United States, dropped by 14 percent when the number of medical marijuana dispensaries increased from one to two, and declined by 21 percent with a similar increase in recreational marijuana dispensaries.

 

Two things might be driving the reduction in opioid-related deaths in communities with more cannabis dispensaries, says W. David Bradford, PhD, a professor of public policy and administration at the University of Georgia in Athens who wasn’t involved in the study.

e-mail icon
Continue reading

(Another) Study – Medical Cannabis And Prescription Opioids

A study observing the impact of medical cannabis on prescribed opioid usage in chronic pain patients has revealed interesting results.

The US opioid epidemic claimed 47,600 lives in 2017 and it’s estimated 10.3 million people were misusing opioids in 2018 – a staggering 3.7% of the US population. It’s thought medical cannabis may be able to help address the situation and various studies have indicated this might be the case.

One of the more recent studies involved 525 patients from three medical cannabis practice sites who had used prescription opioid medications to treat chronic pain for at least 3 months continuously – and were using medical cannabis in combination with these medications.

40.4% reported they stopped all opioids while 45.2% reported some decrease. 13.3% reported no change in opioid usage, and 1.1% reported an increase. Furthermore, 48.2% reported a 40-100% decrease in pain, 80.2% reported an improved ability to function and 87% an improved quality of life using medical cannabis. 62.8% didn’t want to take opioids in the future.

“We believe our results lend further support that medical cannabis provided in a standardized protocol can lead to decreased pain and opioid usage, improved function, and quality of life measures, and even complete cessation of opioids in patients with chronic pain treated by opioids,” state the paper’s authors.

A change in pain level was reportedly not affected by age and gender. However, the younger age group (

Could cannabis help patients suffering from Parkinson’s Disease?

A pilot study being conducted at the National Centre for Naturopathic Medicine is investigating a controversial topic – how cannabis, medicinal or recreational, is used, accessed and how it may benefit individuals with Parkinson’s Disease.

Whilst recreational cannabis remains illegal in Australia, much of the research and thus the path to legalisation has been largely limited to the management of specific symptoms, such as pain.

Previous international research has shown some benefits of cannabis use in the improvement of both motor and non-motor symptoms of Parkinson’s Disease, a debilitating neurodegenerative disease that affects one in every 308 Australians.

Dr Andrea Bugarcic and Dr Janet Schloss from the National Centre for Naturopathic Medicine are leading the study and urge all patients who might be eligible to participate in the survey which will run until the end of February 2021.

While research has been done on the topic of cannabis use in neurodegenerative diseases in other countries, this aspect of self-management by Parkinson’s Disease patients in Australia has not yet been explored.

e-mail icon
Continue reading

Does Marijuana Work Better Than Sleeping Pills For Insomnia?

If you’re not currently receiving any treatment for insomnia, or if your current treatment isn’t enhancing the duration and quality of your sleep, you may want to give cannabis a try.

Ask any CBD or THC supplier and one of the main referrals for their product is sleep disorders. Known to be a natural sleep aid, cannabis and CBD oil has been proven to assist with insomnia and better sleep.

Here are five things to understand about the effect cannabis has on getting a better night’s sleep:

1) It might be better to choose the bong over the bottle. In fact, while booze is proven to shorten your slumber and decrease REM patterns in sleep, cannabis has both intoxicating and relaxant properties which can bring sweeter dreams and easier waking.

2) Long-term use of cannabis may lessen the drug’s effects, and withdrawal can cause not only insomnia but also a rebound REM effect that temporarily produces more vivid and frequent dreaming.

sleeping in
Continue reading

Review of Studies Finds Cannabis May Not Be Linked To Cognitive Dysfunction In Seniors

Marijuana use among older adults may not have a major effect on cognitive function.

That is the takeaway of a new review published late last year in Archives of Clinical Neuropsychology. Reviewing a combination of both human and animal trials, the researchers examined the studies “to critically examine the extent of literature on this topic and highlight areas for future research” on the effect of cannabis exposure on older subjects.

“Six articles reported findings for older populations (three human and three rodent studies), highlighting the paucity of research in this area. Human studies revealed largely null results, likely due to several methodological limitations,” the researchers wrote. “Better-controlled rodent studies indicate that the relationship between [THC] and cognitive function in healthy aging depends on age and level of THC exposure. Extremely low doses of THC improved cognition in very old rodents. Somewhat higher chronic doses improved cognition in moderately aged rodents. No studies examined the effects of cannabidiol (CBD) or high-CBD cannabis on cognition.”

In conclusion, the authors wrote that their “systematic scoping review examined current research on the relationship between cannabis use and cognitive function in healthy aging and provides a starting point for future research,” as quoted by NORML.

“Ultimately, given the recent increase in cannabis use among older adults, future human research should examine the relationship between both early and later-life cannabis use on cognitive function within more homogenous, older adult samples of people who use cannabis,” they wrote.

e-mail icon
Continue reading

Health Insurance for Medical Marijuana Is Now a Reality

Cannabis is legal in some form in 34 U.S. states, with five more pending legalization. Of those states, most have legalized all forms of cannabis for medicinal purposes, though a handful have only legalized CBD oil.

Despite increased legalization, there remains a major void in the medical cannabis market: health insurance. 

The reason major health insurance carriers won’t cover cannabis is they require their drug formulary approved by the FDA before it can be covered in their medical plans. With cannabis still classified as a Schedule I drug at the federal level, no such drug has been approved with exception of Epidiolex, an FDA-approved CBD-based epilepsy medication developed by GW Pharmaceuticals. 

There are a handful of health insurers that do provide coverage for cannabis, but they don't advertise their coverage, leaving patients instead to rely on word of mouth. But with cannabis and cannabis-based products growing more and more popular, so too is the need for cannabis-based health insurance. 

Introducing a Cannabis Health Plan

e-mail icon
Continue reading

Can CBD Protect You from the Flu?

There have been a number of studies surrounding immunity, the flu and how the body responds to infection. These studies have also looked at how CBD and other cannabinoids could impact that response. Could CBD help people to feel better more naturally and possibly not feel as sick when they get sick.

Cannabinoids Suppress the Production of Cytokines in the Body

Cytokines are interleukin tumor necrosis factor. These are the chemicals that affect you when you get sick with a virus. Cytokines create body aches, nausea, headache, loss of appetite, all of the symptoms that make you feel terrible.

In one study involving mice, mice were either pretreated with CBD or they were left without any treatment with cannabinoids. Mice that were pretreated with CBD were then exposed to the flu virus. They had reductions in certain immune responses by up to 87 percent. The number of cytokines were significantly reduced. The mice didn’t feel as sick as their counterpart mice who weren’t pretreated with CBD.

It looked as though treatment with CBD in this model reduced the response to the viral infection. This allowed the mouse to continue to operate through his usual activities instead of becoming terribly sick with the flu virus.

This May Have Significant Implications in How We Might Manage Ourselves During Cold and Flu Seasons

With a few larger studies, we can look at human models and see how we could compare in a randomized trial. We could look at humans that are treated with CBD or other cannabinoids, and some that aren’t. Then analyze their response to colds or other infections. In the future, we may place CBD in the medicine cabinet right next to the probiotics. We could try to control our immune response to the diseases that affect our community in the fall and winter months.

e-mail icon
Continue reading

Opioid Deaths Fall When Cannabis Stores Rise, Analysis Suggests

Access to legal cannabis stores was linked with fewer opioid deaths in the U.S., a new analysis suggested.

The number of marijuana dispensaries in a county was negatively related to log-transformed opioid mortality rate, adjusted for age (β -0.17, 95% CI -0.23 to -0.11), reported Balázs Kovács, PhD, of Yale University School of Management in New Haven, Connecticut, and Greta Hsu, PhD, of University of California Davis Graduate School of Management.

 

This means that increasing the number of storefront dispensaries from one to two was tied to a 17% reduction in death rates of all opioid types, and an increase from two to three stores was associated with a further 8.5% reduction in mortality, Kovács and Hsu noted.

The relationship was stronger -- leading to an estimated 21% drop in mortality -- when only deaths from synthetic non-methadone opioids like fentanyl were considered (β -0.21, 95% CI -0.27 to -0.14), they wrote in The BMJ.

"We find this relationship holds for both medical dispensaries, which serve only patients who have a state-approved medical card or doctor's recommendation, as well as for recreational dispensaries, which sell to adults 21 years and older," Kovács said.

e-mail icon
Continue reading

Several bills propose tweaks for medical marijuana in North Dakota

North Dakota lawmakers heard several bills on Tuesday aimed at improving the state’s medical marijuana program for patients.

Voters in 2016 approved medical marijuana; the 2017 Legislature implemented the program. It has 4,450 active patient cards, with eight dispensaries operating in the state, including one in Bismarck. The state’s first dispensary opened in Fargo in March 2019.

The bills would tweak aspects of the state’s medical marijuana laws, allowing edible products, growing of plants and additional caregivers for patients.

 

Patient advocacy

Rep. Matt Ruby, R-Minot, introduced House Bill 1359 to the House Human Services Committee. The bill would:

Restructure the state’s medical marijuana advisory board to include representation from manufacturing facilities, dispensaries and patients

e-mail icon
Continue reading

Medical marijuana dispensaries are opening in Lebanon and Carthage

Two Ozarks communities, both with roughly 15,000 people living in them, are getting medical marijuana dispensaries.

Lebanon's first licensed dispensary opened Friday morning, and one in Carthage is expected to open Saturday.

Blue Sage Cannabis Company, located at 1210 Deadra Drive on the east side of Lebanon, attracted "several hundred" people for its grand opening, the owner of both stores told the News-Leader on Monday.

LeAnne Dickerson is an independent pharmacist based in Garden City and licensed in Missouri since 1997, according to state records.

"It went awesome," Dickerson said of the grand opening in Lebanon. Patients who came to the dispensary last weekend provided "really good feedback" for the patient-counseling staff.

Blue Sage Cannabis Company opened Friday, Jan. 22, 2021 in Lebanon, Missouri. A second store in Carthage, pictured in this recent publicity photo, is to open Saturday, Jan. 29, 2021.
Continue reading

Would a National Medical Marijuana Market Allow Smoking? Don't Hold Your Breath

One exciting development that the United States could see this year in terms of marijuana is a less restrictive attitude toward medicinal use. As part of the party’s campaign platform in the 2020 election, the Democrats, which are set to control the majority in Congress, revealed that “we will support legalization of medical marijuana.”

Although the statement is vague and could mean many things, the federal government is expected to make moves this year to further medical cannabis. Only we wouldn’t hold our breath on Americans being able to consume it by smoking.

Smoking is, by far, the most common consumption method for a lot of cannabis users. Rolling a joint or packing a bowl is just how medicating was done before legalization began to take hold across the country and bring to life a wealth of new products. Still, even with the advent of edibles, drinks and capsules, many people still enjoy smoking. And most don’t think it poses a significant health risk either. They believe that smoking marijuana is far safer than smoking cigarettes because it doesn’t contain all of the harsh chemicals used by the tobacco companies. However, recent studies show this claim is more myth than fact. Marijuana smoke may be just as harmful.

Researchers at the Dana-Farber Cancer Institute in Boston recently determined that marijuana smokers are putting themselves at just as much risk as those who use tobacco. Their study, published in the journal EClinicalMedicine, shows cannabis smokers have higher concentrations of dangerous toxins like naphthalene, acrylamide and acrylonitrile in their system than non-smokers. These chemicals have been linked to anemia, liver and neurological issues, not to mention cancer.  

The results are alarming considering that cancer patients often use marijuana to treat their symptoms.

e-mail icon
Continue reading

Cash For Ireland’s Medical Cannabis Scheme

Ireland’s Minister for Health, Stephen Donnelly TD, has announced provision for the delivery and funding of the country’s Medicinal Cannabis Access Programme.

Ireland’s then-Minister for Health Simon Harris signed legislation to kick off a formal medical cannabis program in Ireland in July last year and it was expected the program would be up and running (funded) by the end of 2020. But better late than never.

Ireland’s Budget in October 2020 saw an extra €4 billion added to the Health Budget, and thanks to this extra funding the Medicinal Cannabis Access Programme has been added to the HSE (Health Service Executive) Service Plan for 2021.

“The purpose of this Programme is to facilitate compassionate access to cannabis for medical reasons, where conventional treatment has failed,” said Minister Donnelly. “It follows the clear pathway laid out by the Health Products Regulatory Authority in their expert report ‘Cannabis for Medical Use – A Scientific Review’.”

Work on establishing the program began back in March 2017 after the report was tabled; prepared at the request of Ireland’s Minister for Health – so it’s been a  long road to get to this point.

e-mail icon
Continue reading

CBD could be the bacterial-killing answer to gonorrhoea

Australian researchers report they have shown synthetic CBD can kill a range of bacteria responsible for conditions like gonorrhoea, meningitis and legionnaires disease, a find they suggest could lead to the first new class of antibiotics for resistant bacteria in six decades.

To test the antimicrobial activity of cannabidiol (CBD), the research team from the University of Queensland used lab models to mimic a two-week patient treatment and see how quickly “the bacteria mutated to try to outwit CBD’s killing power,” notes a university release.

Researchers found “for the first time that cannabidiol can selectively kill a subset of Gram-negative bacteria that includes the ‘urgent threat’ pathogen Neisseria gonorrhoeae,” the study abstract reports.

The collaboration between the university and Botanix Pharmaceuticals, which contributed formulation expertise, demonstrated that CBD can penetrate and kill a wide range of bacteria, associate professor Mark Blaskovich says in the university statement.

“This is the first time CBD has been shown to kill some types of Gram-negative bacteria. These bacteria have an extra outer membrane, an additional line of defence that makes it harder for antibiotics to penetrate,” Blaskovich explains in the statement.


Continue reading

Cannabis Antibiotics: Answer to Disease-Resistant Bacteria

There’s been a lot of talk about how, and whether, cannabis can be used in place of antibiotics. Centuries of natural medicine traditions tell us ‘yes’ already, but now the Western medicine world is finally catching up. New research highlights how cannabis antibiotics are a likely and reasonable answer to the issue of disease-resistant bacteria.

If you haven’t tried delta-8 THC yet, then you’re using cannabis the old-fashioned way. Delta-8 provides a new way to use cannabis with less anxiety, and less psychoactive effects. This makes it the optimal form of THC for many people. Check it out to see for yourself. We’ve got all the best Delta-8 THC deals for you to get acquainted with this new form of cannabis medicine.

Let’s go back in time first

There are tons of natural medicine traditions that have existed on the planet through the history of man. Two of the more well-known, which are still in existence today, are Ayurvedic medicine out of India, and Traditional Chinese Medicine (TCM) out of China. In Ayurveda, medical cannabis was used since 1000 b.c., with one of the reasons being as an antibiotic. This included topical use for skin infections, as well as for ailments like tuberculosis. Imagine that, information was figured out 1000 years before Jesus was supposed to have walked the earth, and researchers of today are only now catching up? Perhaps we should look at history more often.

When it comes to Traditional Chinese Medicine and cannabis, there’s a striking lack of information published, and not because it doesn’t exist. While most sites cite the lack of translation to Western languages for the void in information, this explanation sounds suspect. This is a popular topic, it goes against logic to assume that no one has bothered to translate for the English speaking world.

My guess is that as the pre-eminent natural medicine tradition, it bodes better for Western medicine practitioners to keep this information out as it tends to threaten the pharmaceutical industry (highlighted by this very article and the use of a natural medicine to combat bacterial infections). It is understood that cannabis has been written on within the medical tradition for at least 1800 years, and that all parts of the plant were used. Some publications say that hemp has been cultivated in China for as many as 4000 years. Again, there seems to be a block in getting this information to the Western world. You can draw your own conclusions as to why.

cannabis antibiotics
Continue reading

Inflammation and obesity: Can cannabis help break the cycle?

Like many chronic lifestyle-related diseases, inflammation is at the core. Obesity may be no different.

When it comes to obesity, doctors oftentimes prescribe medications to treat the accompanying co-morbidities, such as high blood pressure, elevated cholesterol and dysregulated blood glucose. Some note, however, that inflammation is at the root of high blood pressure, high cholesterol and high blood sugar.

 
 
 

Substances called cytokines can create other health issues, including insulin resistance. Insulin resistance is a precursor of Type 2 diabetes, which is frequently, but not always, related to obesity.

Chronic diseases, such as diabetes, can happen over time as a result of less-than-optimal lifestyle habits. A diet high in sugar and processed food raises blood sugar, which signals the body to make insulin to clear glucose from the bloodstream. Chronic consumption of these foods forces the body to produce increasing amounts of insulin to keep up with the influx of sugar.

Eventually, the body becomes desensitized and insulin stops responding. The result can be high blood sugar, which causes more inflammation, further exacerbating insulin resistance.


Continue reading

WeedLife.com